Activated Protein C
Showing 1 - 25 of >10,000
Hemophilia B With Inhibitor, Hemophilia B Trial (SerpinPC)
Not yet recruiting
- Hemophilia B With Inhibitor
- Hemophilia B
- (no location specified)
Mar 16, 2023
Ischemic Stroke Trial (3K3A-APC, Placebo)
Not yet recruiting
- Ischemic Stroke
- 3K3A-APC
- Placebo
- (no location specified)
Jul 29, 2022
Sidestream Dark-Field Imaging of Intestinal Microcirculation
Active, not recruiting
- Sepsis
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II Health Sciences Cetnre
Mar 7, 2022
Resistance, APC Trial in Guyuan (Resistance training that combines water and land)
Completed
- Resistance, APC
- Resistance training that combines water and land
-
Guyuan, Ningxia, ChinaGuo wei
Sep 9, 2021
C Reactive Protein and Its Correlation With Fetal Ultrasound
Recruiting
- Threatened Miscarriage
- Serum C reactive protein (CRP) level
- Ultrasound
-
Cairo, EgyptAl-Hussein University Hospital
Aug 23, 2023
Diagnostic Importance of C-reactive Protein From Blood and
Not yet recruiting
- Acute Appendicitis
- Blood specimen collection for C-reactive protein (CRP) and WBC (white blood cells). Saliva specimen collection for analysis of CRP levels
- (no location specified)
Sep 20, 2023
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin
Not yet recruiting
- Juvenile Idiopathic Arthritis
- fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
- (no location specified)
Aug 29, 2023
High Sensitivity C Reactive Protein and Total Leucocytic Count
Not yet recruiting
- Abortion Early
- maternal serum C reactive protein
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)
Active, not recruiting
- Neurofibromatosis 1
- Neurofibroma Plexiform
-
Shanghai, China
- +1 more
Jan 13, 2023
C-Reactive Protein/Albumin Ratio and Acne Vulgaris
Completed
- Acne Vulgaris
- Biochemical blood analysis
-
Erzurum, TurkeyAtaturkU
Aug 21, 2023
C-Reactive Protein /Albumin Ratio in Evaluation of Disease
Not yet recruiting
- Inflammatory Bowel Diseases
- CRP/Albumin ratio in IBD
- (no location specified)
Feb 21, 2023
Periodontitis Trial in Catania (Non-surgical periodontal treatment)
Completed
- Periodontitis
- Non-surgical periodontal treatment
-
Catania, ItalyAOU Policlinico G. Rodolico
Apr 18, 2023
Aging, Muscle Atrophy or Weakness, Sarcopenia in Elderly Trial in Eugene (Fatiguing Exercise)
Recruiting
- Aging
- +3 more
- Fatiguing Exercise
-
Eugene, OregonUniversity of Oregon
Jun 26, 2023
Systemic Infection Trial in Belo Horizonte (C reactive protein)
Recruiting
- Systemic Infection
- C reactive protein
-
Belo Horizonte, Minas Gerais, BrazilHospital das Clínicas da Universidade Federal de Minas Gerais
Apr 24, 2023
Poisoning Severity Score, Serum Procalcitonin and C-reactive
Not yet recruiting
- Acute Hydrocarbon Toxicity
- serum procalcitonin
- C-reactive protein
-
Cairo, EgyptAin Shams university Hospital
Nov 21, 2023
Effect of Food Supplement Trial in Davis (Placebo, Hydrolized Collagen, PrimaColl)
Recruiting
- Effect of Food Supplement
- Placebo
- +3 more
-
Davis, CaliforniaHickey Laboratory
Aug 18, 2022
Acute Febrile Illness, Use of Antimicrobial Agents, C-reactive Protein Level Trial (C-reactive Protein Rapid Diagnostic Test)
Not yet recruiting
- Acute Febrile Illness
- +2 more
- C-reactive Protein Rapid Diagnostic Test
- (no location specified)
Dec 23, 2022
Exercise Training Trial in Toronto (Endurance exercise)
Completed
- Exercise Training
- Endurance exercise
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport at the University of
Nov 15, 2023
COVID-19 Trial in Sukoharjo (Calcitriol, Placebo)
Completed
- COVID-19
- Calcitriol
- Placebo
-
Sukoharjo, Central Java, IndonesiaUniversitas Sebelas Maret Hospital
Mar 9, 2023
COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19
Not yet recruiting
- COVID-19
- Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
- Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
- (no location specified)
Jun 19, 2023
Hepatocellular Carcinoma Trial in New Taipei City, Hualien City, Taipei (ATL administration)
Recruiting
- Hepatocellular Carcinoma
- ATL administration
-
New Taipei City, Taiwan (R. O. C.), Taiwan
- +3 more
Jun 10, 2022
CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy
Not yet recruiting
- Type 2 DM /Diabetic Nephropathy
- (no location specified)
Jan 28, 2023